Across TCGA pan-cancer cohorts, KRT18P44 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of KRT18P44’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where KRT18P44 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types KRT18P44 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

STAD, LUAD, and HNSC are the cancer types where KRT18P44 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KRT18P44 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	+0.055	<.001	7	view →
LUAD	All	III,IV	+0.050	.012	5	view →
HNSC	Female	IV	+0.043	.026	1	view →
THCA	Female	All	−0.011	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: KRT18P44 RNA expression & survival · all KRT18P44 data types